Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus.

MLA

Borgia, R.Ezequiel, et al. “Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus.” Arthritis & Rheumatology (Hoboken, N.J.), vol. 70, no. 4, Apr. 2018, pp. 616–24. EBSCOhost, https://doi.org/10.1002/art.40417.

APA

Borgia, R. E., Gerstein, M., Levy, D. M., Silverman, E. D., & Hiraki, L. T. (2018). Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.), 70(4), 616–624. https://doi.org/10.1002/art.40417

Chicago

Borgia, R Ezequiel, Maya Gerstein, Deborah M Levy, Earl D Silverman, and Linda T Hiraki. 2018. “Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus.” Arthritis & Rheumatology (Hoboken, N.J.) 70 (4): 616–24. doi:10.1002/art.40417.